SCHEMBL3320709

SCHEMBL3320709

CC(C(=O)c1ccccn1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.58
POLB P06746 2/20 0.55
LMNA P02545 4/20 0.55
NAPRT Q6XQN6 1/20 0.55
P4HTM Q9NXG6 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 4/20 0.53
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
KDM4E B2RXH2 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HTT P42858 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
OPRK1 P41145 1/20 0.50
KMT2A Q03164 1/20 0.50
MITF O75030 1/20 0.49
EPHX2 P34913 1/20 0.49
NPC1 O15118 2/20 0.46
PKM P14618 2/20 0.46
RAB9A P51151 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31388173 0.83 PTGS1 (0.61) GSK3BLMNARAB9AMAPK1MAPT
SCHEMBL13729034 0.81 POLB (0.44) GSK3BPOLBLMNASMN1; SMN2HTT
SCHEMBL29915632 0.81 GSK3B (0.66) GSK3BPOLBLMNANAPRTP4HTM
SCHEMBL888686 0.81 GSK3B (0.66) GSK3BPOLBLMNANAPRTP4HTM
SCHEMBL9784154 0.80 GSK3B (0.59) GSK3BLMNANAPRTP4HTML3MBTL1
SCHEMBL5160643 0.80 GSK3B (0.59) GSK3BPOLBLMNANAPRTP4HTM
SCHEMBL14549447 0.79 GSK3B (0.63) GSK3BPOLBLMNANAPRTP4HTM
SCHEMBL6823751 0.79 POLB (0.47) GSK3BPOLBLMNANAPRTP4HTM
SCHEMBL9367982 0.79 GSK3B (0.68) GSK3BLMNANAPRTP4HTML3MBTL1
SCHEMBL28755279 0.79 GSK3B (0.58) GSK3BPOLBLMNANAPRTP4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100121065-A1 Phosphors with High Luminous Efficiency and Display Device Containing Them GRACEL DISPLAY INC. (KR) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100121065-A1 Phosphors with High Luminous Efficiency and Display Device Containing Them PPIP5K2, ACP1, INPP5B GSK3B 2775/4885POLB 3493/4885LMNA 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.